ResMed (RMD) Stock Chart & Stock Price History $241.55 +3.43 (+1.44%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ResMed Stock Price Performance 5 Day Performance+2.90%1 Month Performance+0.62%3 Month Performance+7.76%6 Month Performance+10.66%Year-To-Date Performance+40.42%1 Year Performance+58.36% Receive RMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO RMD Stock Chart for Thursday, November, 21, 2024 RMD Chart by TradingView ResMed Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$238.04$241.55+1.47%$242.47$236.72549,312 shs$35.46 billion11/19/2024$239.42$238.04-0.58%$240.67$236.62710,758 shs$34.94 billion11/18/2024$234.74$239.42+1.99%$240.22$234.91756,885 shs$35.15 billion11/15/2024$231.43$234.77+1.44%$235.07$231.261.12 million shs$34.46 billion11/14/2024$235.44$231.43-1.70%$236.89$231.181.08 million shs$33.97 billion11/13/2024$247.11$235.44-4.72%$247.73$235.36993,700 shs$34.56 billion Get the Latest News and Ratings for RMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$248.69$247.11-0.64%$249.23$246.19736,693 shs$36.27 billion11/11/2024$252.38$248.69-1.46%$252.99$248.43872,087 shs$36.51 billion11/08/2024$248.42$252.26+1.55%$255.16$248.76930,159 shs$37.03 billion11/07/2024$245.63$248.42+1.14%$248.55$243.62815,806 shs$36.47 billion11/06/2024$245.74$245.63-0.04%$250.00$241.98789,821 shs$36.06 billion11/05/2024$243.61$245.74+0.87%$246.51$241.281.01 million shs$36.07 billion11/04/2024$244.28$243.61-0.27%$247.75$242.841.24 million shs$35.76 billion11/01/2024$242.47$244.28+0.75%$246.77$241.121.12 million shs$35.86 billion10/31/2024$242.89$242.47-0.17%$243.67$240.531.17 million shs$35.59 billion10/30/2024$244.42$242.89-0.63%$245.85$241.061.11 million shs$35.65 billion10/29/2024$246.83$244.42-0.98%$250.09$243.841.49 million shs$35.87 billion10/28/2024$256.07$246.83-3.61%$259.33$246.271.74 million shs$36.23 billion10/25/2024$239.05$256.07+7.12%$260.49$252.803.25 million shs$37.58 billion10/24/2024$237.40$239.05+0.70%$243.99$237.461.71 million shs$35.09 billion10/23/2024$239.98$237.40-1.08%$240.22$235.081.02 million shs$34.84 billion10/22/2024$240.05$239.98-0.03%$241.17$237.63604,643 shs$35.22 billion10/21/2024$240.00$240.05+0.02%$242.44$238.40937,279 shs$35.27 billion Related Companies Boston Scientific Stock Chart Medtronic Stock Chart Becton, Dickinson and Company Stock Chart Edwards Lifesciences Stock Chart IDEXX Laboratories Stock Chart DexCom Stock Chart STERIS Stock Chart Insulet Stock Chart Hologic Stock Chart Baxter International Stock Chart Receive RMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:RMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
